Universal Beteiligungs und Servicegesellschaft mbH Boosts Stake in Chemed Corporation $CHE

Universal Beteiligungs und Servicegesellschaft mbH increased its position in Chemed Corporation (NYSE:CHE) by 29.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,348 shares of the company’s stock after buying an additional 1,682 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned 0.05% of Chemed worth $3,146,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. WCM Investment Management LLC lifted its position in shares of Chemed by 3.8% in the third quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after buying an additional 24 shares in the last quarter. Eukles Asset Management raised its position in Chemed by 0.4% during the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after purchasing an additional 24 shares during the period. Cim LLC raised its position in Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after purchasing an additional 24 shares during the period. Smartleaf Asset Management LLC raised its position in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the period. Finally, HM Payson & Co. raised its position in Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after purchasing an additional 27 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Up 0.3%

Shares of NYSE CHE opened at $425.20 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The business’s 50 day moving average price is $399.29 and its 200-day moving average price is $426.04. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The company has a market cap of $5.64 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.59 and a beta of 0.49.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same period in the prior year, the business posted $5.63 earnings per share. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, sell-side analysts expect that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio is presently 13.08%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 3.33% of the company’s stock.

Wall Street Analyst Weigh In

CHE has been the topic of a number of recent research reports. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Royal Bank Of Canada upped their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday. Finally, Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.